Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture

World Journal of Gastroenterology

Volumn 9, Issue 5, 2003, Pages 921-929

  Su, Qin ^a   Fu, Yong ^a   Liu, Yan Fang ^b   Zhang, Wei ^a   Liu, Jie ^a   Wang, Chun Mei ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; LAMININ; LAMININ RECEPTOR;

ARTICLE; CELL CULTURE; CELL LINE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER PARENCHYMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; WESTERN BLOTTING;

EID: 0038205806     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i5.921     Document Type: Article

References (64)

1. Moll R, Franke WW, Schiller DL, Gerger B, Krepler R. The catalog of human cytokeratins: Pattern of expression in normal epithelia tumors and cultured cells. Cell 1982; 31: 11-24
2. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas, a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-447
3. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications, and limitations. Lab Invest 1985; 52: 243-256
4. Su Q, Gong MZ, Liu YF. Immunocytochemical localization of epidermal keratin in the livers of rat and its embryos. Dongwu Xuebao 1988; 34: 344-347
5. Su Q, Liu YF, Gong MZ. Mechanism of the morphogenesis of intrahepatic bile ducts in rat embryos, a cytokeratin and laminin-immunohistochemical study. Di-Si Junyi Daxue Xuebao 1994; 15: 168-172
6. Van Eyken P, Sciot R, Desmet VJ. Intrahepatic bile development in the rat: A cytokeratin-immunohistochemical study. Lab Invest 1988; 59: 52-59
7. Van Eyken P, Sciot R, Callea F, Van Der Steen K, Moerman P, Desmet VJ. The development of intrahepatic bile ducts in man: A keratin-immunohistochemical study. Hepatology 1988; 8: 1586-1595
8. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ. Cytokeratin expression in hepatocellular carcinoma: An immunohistochemical study. Hum Pathol 1988; 19: 562-568
9. Liu YF, Su Q, Gong MZ. Expression of cytokeratins in hepatocellular and cholangiocellular carcinomas and their cell lines of human and rat. Cell Vision 1996; 3: 119-125
10. Ray MB. Distribution of patterns of cytokeratin antigen determinants in alcoholic and nonalcoholic liver diseases. Hum Pathol 1987; 18: 61-66
11. Ray MB, Mendenhell CL, French SW, Gartside PS. Bile duct changes in alcoholic liver disease. Liver 1993; 13: 36-45
12. Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver disease: Evidence that hepatocytes can express 'bile-duct type' cytokeratins. Histopathol 1989; 15: 125-135
13. Su Q, Liu YF, Zhang YG. The abnormal cytokeratin expression in HBV-caused hepatitis, early-cirrhotic and cirrhotic livers, its mechanism and significance. Zhonghua Binglixue Zazhi 1992; 21: 287-289
14. 4-injured liver. Dianzi Xianwei Xuebao 1993; 12: 469-475
15. Su Q, Liu YF, Wei ZQ. Abnormal cytokeratin expression in experimental liver injury caused by carbon tetrachloride administration in rats. Cell Vision 1996; 3: 297-305
16. Su Q, Liu YF. The abnormal cytokeratin expression in hepatocytes and its mechanism in three models of experimental liver injury in rat. Di-Si Junyi Daxue Xuebao 1993; 14: 257-262
17. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993; 13: 113-122
18. Fu Y, Su Q, Liu YF. Expression of cytokeratins in hepatocytes and hepatic extracellular matrix. Xibao Yu Fenzi Mianyixue Zazhi 2001; 17(Suppl): 80-82
19. Hahn E, Wick G, Pencev D, Templ R. Distribution of basement membrane proteins in normal and fibrotic liver: Collagen type IV, laminin, and fibronectin. Gut 1980; 21: 63-71
20. Bianchi FB, Biagini G, Ballardini G, Cenacchi G, Fanccani A, Pisi E, Laschi R, Liotta L, Garbisa S. Basement membrane production by hepatocytes in chronic liver disease. Hepatology 1984; 4: 1167-1172
21. Clement B, Rescan PY, Baffet G, Loreal O, Lehry D, Campion JP, Guillouzo A. Hepatocytes may produce laminin in fibrotic liver and in primary culture. Hepatology 1988; 8: 794-803
22. Martinez-Hernandez A, Delgado FM, Amenta PS. The extracellular matrix in hepatic regeneration: Localization of collagen types I, III, IV, laminin, and fibronectin. Lab Invest 1991; 64: 157-166
23. Reid LM, Fiorino AS, Sigal SH, Brill S, Holst PA. Extracellular matrix gradients in the space of Disse: Relevance to liver biology. Hepatology 1992; 15: 1198-1203
24. 4-induced cirrhosis. Lab Invest 1985; 53: 166-186
25. Bloula SP, Lafon M, Leball B, Dennis JA, Martin AB. Ultrastructure of sinusoids in liver diseases. In: Arias IM, Balabaud C, eds. Sinusoids in Human Liver: Health and Disease. The Netherlands, Rijswijk: The Kupffer Cell Foundation 1988:223-228
26. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990; 99: 466-477
27. Matsumoto S, Yamamoto K, Nagano T, Okamoto R, Ibuki N, Tagashira M, Tsuji T. Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition. Liver 1999; 19: 32-38
28. Morris KM, Aden DP, Knowles BB, Colten HR. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest 1982; 70: 906-913
29. Ting LP, Jeng KS, Chou CK, Su TS, Hu CP, Wong FH, Chang HK, Chang CM. Expression of oncogenes in human hepatoma cell lines. Chung Hua Min Kuo Wei Sheng Wu Chi Mien I Hsueh Tsa Chih 1988; 21: 141-150
30. Shi CH, Shi Y, Shi XY, Zhu DS. Establishment and characterization of a human hepatocellular carcinoma cell line, HCC-9724. Di-Si Junyi Daxue Xuebao 2000; 21: 709-712
31. Yang LJ, Wang WL. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization. World J Gastroenterol 2002; 8: 808-814
32. Hu CM, Liu YF, Shui YF, Xu LQ, Liu CG. Establishment and characterization of a human hepatocellular carcinoma cell line, HCC-9204. Di-Si Junyi Daxue Xuebao 1995; 16: 92-95
33. Li J, Yang XK, Yu XX, Ge ML, Wang WL, Zhang J, Hou YD. Overexpression of p27KIP1 induced cell cycle arrest in G1 phase and subsequent apoptosis in HCC-9204 cell line. World J Gastroenterol 2000; 6: 513-521
34. Dung YC, Zhou RH, Lui FD, Tao YC. Establishment of a human hepatocellular cell line, SMMC7721, and its biologic characteristics. Di-Er Junyi Daxue Xuebao 1980; 1: 5-10
35. Han YP, Su Q, Liu YF. Expression of insulin-like growth factor II in hepatocellular carcinoma cells growing in culture. Di-Si Junyi Daxue Xuebao 1992; 13: 84-87
36. Song ZQ, Hao F, Min F, Ma QY, Liu GD. Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J Gastroenterol 2001; 7: 685-689
37. Wang X, Liu FK, Li X, Li JS, Xu GX. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro. World J Gastroenterol 2002; 8: 253-257
38. Tian G, Yu JP, Luo HS, Yu BP, Yue H, Li JY, Mei Q. Effect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells. World J Gastroenterol 2002; 8: 483-487
39. Su Q, Schröder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus (HBV) X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998; 27: 1109-1120
40. Su Q, Liu YF, Zhang JF, Zhang SX, Li DF, Yang JJ. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression. Hepatology 1994; 20: 788-799
41. Cao XT. An introduction to the statistic software package, SPLM of the Windows version. In: Guo Z-C, ed. Medical Statistics. Beijing: Renmin Junyi Press 1999: 259-270
42. Su Q, Zerban H, Otto G, Bannasch P. Cytokeratin expression is reduced in glycogenotic clear hepatocyte but increased in ground glass cells in chronic human and woodchuck hepadnaviral infection. Hepatology 1998; 28: 347-359
43. Fu Y, Zhang W, Liu YF, Wang CM, Chen D, Liu J, Su Q. Abnormal expression of cytokeratins in hepatocellular carcinoma cell lines and its mechanism. Di-Si Junyi Daxue Xuebao 2001; 22: 598-603
44. Paku S, Schnur J, Nagy P, Thorgeirsson SS. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol 2001; 158: 1313-1323
45. Gournay J, Auvigne I, Pichard V, Ligeza C, Bralet MP, Ferry N. In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: Evidence for dedifferentiation of mature hepatocytes. Lab Invest 2002; 82: 781-788
46. Vessey CJ, De La Hall PM. Hepatic stem cells: A review. Pathology 2001; 33: 130-141
47. Hsia CC, Thorgeirsson SS, Tabor E. Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in "oval cells" of the liver in patients with hepatocellular carcinoma. J Med Virol 1994; 43: 216-221
48. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: Can 'progenitor cells' migrate? J Pathol 2000; 192: 373-378
49. Kiss A, Schnur J, Szabo Z, Nagy P. Immunohistochemical analysis of atypical ductular reaction in the human liver, with special emphasis on the presence of growth factors and their receptors. Liver 2001; 21: 237-246
50. Ma X, Qiu DK, Peng YS. Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis. World J Gastroenterol 2001; 7: 238-242
51. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Human hepatic preneoplasia: Phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 1997; 431: 391-406
52. Libbrecht L, Desmet V, Van Damme B, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: Correlation with putative progenitor cells. J Hepatol 2000; 33: 76-84
53. Steinberg P, Hacker HJ, Dienes HP, Oesch F, Bannasch P. Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 1991; 12: 225-231
54. Gindi T, Ghazarian DM, Deitch D, Farber E. An origin of presumptive preneoplastic foci and nodules from hepatocytes in chemical carcinogenesis in rat liver. Cancer Lett 1994; 83: 75-80
55. Anilkumar TV, Golding M, Edwards RJ, Lalani EN, Sarraf CE, Alison MR. The resistant hepatocyte model of carcinogenesis in the rat: The apparent independent development of oval cell proliferation and early nodules. Carcinogenesis 1995; 16: 845-853
56. Su Q, Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003; 31: 126-133
57. Albrechtsen R, Wewer UM, Thorgeirsson SS. De novo deposition of laminin-positive basement membrane in vitro by normal hepatocytes and during hepatocarcinogenesis. Hepatology 1988; 8: 538-546
58. Cable EE, Isom HC. Exposure of primary rat hepatocytes in long-term DMSO culture to selected transition metals induces hepatocyte proliferation and formation of duct-like structures. Hepatology 1997; 26: 1444-1457
59. Blaheta RA, Kronenberger B, Woitaschek D, Auth MK, Scholz M, Weber S, Schuldes H, Encke A, Markus BH. Dedifferentiation of human hepatocyte by extracellular matrix proteins in vitro: Quantitative and qualitative investigation of cytokeratin 7, 8, 18, 19 and vimentin filaments. J Hepatol 1998; 28: 677-690
60. Nishikawa Y, Tukusashi Y, Kadohama T, Nishimori H, Ogawa K. Hepatocytic cells form bile duct-like structure with a three-dimensional collagen gel matrix. Exp Cell Res 1996; 223: 357-371
61. Kono Y, Yang S, Letarte M, Roberts EA. Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system. Exp Cell Res 1995; 221: 478-485
62. Le Bail B, Faouzi S, Boussarie L, Balabaud C, Bioulac-Sage P, Rosenbaum J. Extracellular matrix composition and integrin expression in early hepatocarcinogenesis in human cirrhotic liver. J Pathol 1997; 181: 330-337
63. Yuan ST, Hu XQ, Lu JP, Kei KH, Zhai WR, Zhang YE. Changes of integrin expression in rat hepatocarcinogenesis induced by 3′-Me-DAB. World J Gastroenterol 2000; 6: 231-233
64. Liu LX, Jiang HC, Liu ZH, Zhou J, Zhang WH, Zhu AL, Wang XQ, Wu M. Integrin gene expression profiles of human hepatocellular carcinoma. World J Gastroenterol 2002; 8: 631-637